Zhang L - Search Results

1

Enhancing adenovirus-mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone.

Lin T, Gu J, Zhang L, Davis JJ, Huang X, Cabbini G, Ji L, Fang B. Lin T, et al. Among authors: zhang l. J Gene Med. 2003 Oct;5(10):868-875. doi: 10.1002/jgm.427. J Gene Med. 2003. PMID: 14533195

2

Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.

Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B. Lin T, et al. Among authors: zhang l. Cancer Res. 2002 Jul 1;62(13):3620-5. Cancer Res. 2002. PMID: 12097263

3

A novel single tetracycline-regulative adenoviral vector for tumor-specific Bax gene expression and cell killing in vitro and in vivo.

Gu J, Zhang L, Huang X, Lin T, Yin M, Xu K, Ji L, Roth JA, Fang B. Gu J, et al. Among authors: zhang l. Oncogene. 2002 Jul 18;21(31):4757-64. doi: 10.1038/sj.onc.1205582. Oncogene. 2002. PMID: 12101414

4

Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

Lin T, Zhang L, Davis J, Gu J, Nishizaki M, Ji L, Roth JA, Xiong M, Fang B. Lin T, et al. Among authors: zhang l. Mol Ther. 2003 Sep;8(3):441-8. doi: 10.1016/s1525-0016(03)00203-x. Mol Ther. 2003. PMID: 12946317 Free article.

5

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F, Chiao P, Fang B. Zhu H, et al. Among authors: zhang l. Mol Ther. 2004 May;9(5):666-73. doi: 10.1016/j.ymthe.2004.02.007. Mol Ther. 2004. PMID: 15120327 Free article.

6

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.

Jacob D, Davis JJ, Zhang L, Zhu H, Teraishi F, Fang B. Jacob D, et al. Among authors: zhang l. Cancer Gene Ther. 2005 Feb;12(2):109-15. doi: 10.1038/sj.cgt.7700773. Cancer Gene Ther. 2005. PMID: 15486557

7

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang B. Lin T, et al. Among authors: zhang l. Oncogene. 2002 Nov 14;21(52):8020-8. doi: 10.1038/sj.onc.1205926. Oncogene. 2002. PMID: 12439752

8

Cell to cell contact required for bystander effect of the TNF-related apoptosis-inducing ligand (TRAIL) gene.

Huang X, Lin T, Gu J, Zhang L, Roth JA, Liu J, Fang B. Huang X, et al. Among authors: zhang l. Int J Oncol. 2003 Jun;22(6):1241-5. Int J Oncol. 2003. PMID: 12738989

9

Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.

Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B. Gu J, et al. Among authors: zhang l. Oncogene. 2004 Feb 12;23(6):1300-7. doi: 10.1038/sj.onc.1207239. Oncogene. 2004. PMID: 14676844

10

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.

Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y, Fang B. Zhang L, et al. Cancer Biol Ther. 2004 Mar;3(3):296-301. doi: 10.4161/cbt.3.3.696. Epub 2004 Mar 16. Cancer Biol Ther. 2004. PMID: 14749540 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134,698 results

Search Page

Filters